Compare FRBA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FRBA | SOPH |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | Switzerland |
| Employees | 336 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.6M | 462.3M |
| IPO Year | N/A | 2021 |
| Metric | FRBA | SOPH |
|---|---|---|
| Price | $19.64 | $8.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $21.67 | $9.75 |
| AVG Volume (30 Days) | 113.9K | ★ 692.1K |
| Earning Date | 10-22-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.61 | $23.25 |
| Revenue Next Year | $5.91 | $24.62 |
| P/E Ratio | $9.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.41 | $3.83 |
| 52 Week High | $21.29 | $8.98 |
| Indicator | FRBA | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 60.96 | 59.31 |
| Support Level | $17.04 | $7.71 |
| Resistance Level | $21.29 | $8.80 |
| Average True Range (ATR) | 0.59 | 0.58 |
| MACD | -0.04 | 0.11 |
| Stochastic Oscillator | 24.53 | 95.42 |
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of business. Its services are Business Banking, Personal Banking, Digital Banking, and Lending.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.